Archean Chemical Industries Ltd - 543657 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Archean Chemical Industries made the audio recording of its earnings conference call for Q1 FY27, held on August 03, 2026, available on its website. This provides investors access to the post-results discussion.
Aug 03 2026 18:54:10
Archean Chemical Industries Ltd - 543657 - Board Meeting Outcome for Board Meeting Outcome 30.07.2026
Archean Chemical Industries' board approved Q1 FY27 consolidated financial results on July 30, 2026. Consolidated revenue grew 11.9% YoY to ₹327.20 crores, while net profit decreased by 24.4% to ₹30.35 crores. The results were reviewed by the Audit Committee and include a limited review report by statutory auditors.
Jul 30 2026 20:30:27
Archean Chemical Industries Ltd - 543657 - Board Meeting Intimation for Intimation Of Board Meeting
Archean Chemical Industries board will convene on July 30, 2026, to consider and approve the financial results for the first quarter of FY27. This meeting will review both standalone and consolidated performance for the period ended June 30, 2026.
Jul 18 2026 16:35:29
Archean Chemical Industries Ltd - 543657 - General Update
Archean Chemical's invested company, Offgrid Energy Labs Inc., inaugurated its first Zinc Bromide based battery pilot manufacturing facility in the UK on July 07, 2026. This 10 MWh demonstration line marks a transition to commercial pilot-scale production for long-duration energy storage.
Jul 15 2026 18:27:30
Archean Chemical Industries Ltd - 543657 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Archean Chemical Industries' promoter, Chemikas Speciality LLP, disclosed a series of share pledge creations and releases. A net increase in pledged shares was reported, with 12.41% of the company's capital now held as pledged.
Jul 13 2026 14:34:03
Archean Chemical Industries Ltd - 543657 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Archean Chemical's promoter, Chemikas Speciality LLP, reported a net reduction of 1.35 million pledged shares, indicating deleveraging. This resulted from releasing 2.2 million shares (1.78% of capital) while pledging 0.85 million shares (0.69%).
Jul 13 2026 14:32:47
Read More